Kathmandu. GD Pharmaceuticals is going to launch an IPO. The company has also called for a special general meeting to approve the IPO proposal.
The special general meeting of the company is scheduled for June 1. The meeting will begin at 8:00 am at the company’s registered office in Kathmandu.
The meeting will approve the proposal to bring the IPO to the general public. The meeting will also endorse a proposal to amend the Memorandum of Association and Articles of Association to increase the capital of the company.
The meeting will endorse a proposal authorizing the Board of Directors to sell and allocate shares to adjust the liabilities of the company. The meeting will also pass a proposal to authorize the Board of Directors to implement the suggestions and directives received from the regulatory body while amending the Memorandum of Association and Regulations.
